CG

Charles A. Glass

BP Biomarin Pharmaceutical: 13 patents #6 of 139Top 5%
OP Ortho-Mcneil Pharmaceutical: 3 patents #114 of 449Top 30%
📍 Novato, CA: #42 of 607 inventorsTop 7%
🗺 California: #30,698 of 386,348 inventorsTop 8%
Overall (All Time): #234,022 of 4,157,543Top 6%
19
Patents All Time

Issued Patents All Time

Showing 1–19 of 19 patents

Patent #TitleCo-InventorsDate
11549000 Cellular glycosaminoglycan compositions and methods of making and using Bryan THACKER, Jeffrey D. Esko 2023-01-10
10793894 Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition Brett E. Crawford, Jillian R. Brown, Jim R. Beitel, Robin M. Jackman 2020-10-06
10683530 Detection of oligosaccharides Brett E. Crawford, Jillian R. Brown 2020-06-16
10677786 Methods of diagnosing mucopolysaccharidosis (MPS) I and methods of monitoring treatment of MPS by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker Brett E. Crawford, Jillian R. Brown, Jim R. Beitel, Robin M. Jackman 2020-06-09
10260084 Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition Brett E. Crawford, Jillian R. Brown, Jim R. Beitel, Robin M. Jackman 2019-04-16
9915649 Methods of determining the presence, identity, and/or severity of mucopolysaccharidosis (MPS) VI and IVA Brett E. Crawford, Jillian R. Brown, Jim R. Beitel, Robin M. Jackman 2018-03-13
9796999 Detection of oligosaccharides Brett E. Crawford, Jillian R. Brown 2017-10-24
9677116 Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition Brett E. Crawford, Jillian R. Brown, Jim R. Beitel, Robin M. Jackman 2017-06-13
9340822 Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker Brett E. Crawford, Jillian R. Brown, Jim R. Beitel, Robin M. Jackman 2016-05-17
9222120 Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition Brett E. Crawford, Jilllian R. Brown, Jim R. Beitel, Robin M. Jackman 2015-12-29
9029530 Detection of oligosaccharides Brett E. Crawford, Jillian R. Brown 2015-05-12
8809009 Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker Brett E. Crawford, Jillian R. Brown, Jim R. Beitel, Robin M. Jackman 2014-08-19
8771974 Methods of determining the presence and/or amount of a biomarker to determine the presence, identity, and/or severity of a lysosomal storage or neurological disorder Brett E. Crawford, Jillian R. Brown, Jim R. Beitel, Robin M. Jackman 2014-07-08
8592140 Detection of oligosaccharides Brett E. Crawford, Jillian R. Brown 2013-11-26
8232073 Quantification of non-reducing end glycan residual compounds Brett E. Crawford, Jillian R. Brown, Jim R. Beitel, Robin M. Jackman 2012-07-31
8183003 Polymer end group detection Brett E. Crawford, Jillian R. Brown 2012-05-22
7186803 Human vanilloid receptor VR3 protein Adrienne Dubin, Arne Huvar, Mark G. Erlander 2007-03-06
7094877 Human vanilloid receptor VR3 protein Adrienne Dubin, Arne Huvar, Mark G. Erlander 2006-08-22
6455278 DNA encoding human vanilloid receptor VR3 Adrienne Dubin, Arne Huvar, Mark G. Erlander 2002-09-24